Tender

Licensing Spironolatone for Acne in Women

NHS ENGLAND

  • Contract Timeline

    Publication Date

    5th September 2024 18:21:47 PM

    Tender Deadline

    7th October 2024 11:00:00 AM   24 days remaining

  • Contract Summary

    NHS England requires a supplier to apply for a major (type II) MHRA Marketing Authorisation variation for spironolactone. The variation is to add a new indication to the current licence (marketing authorisation) for treating acne in women. The Successful Supplier would need to prepare a dossier for the MHRA including a Risk Management Plan, apply for the licence variation, and if granted update their licence, Summary of Product Characteristics and patient information leaflet with the new indication and related data.

    To register an interest in responding to this opportunity and obtain a copy of the tender documents please go to: http://health.atamis.co.uk. All communications and Request for Information submissions will be conducted via Atamis. The portal can be accessed at any time of the day and it is free to register.

  • Contract Details

    Open Contracting ID

    ocds-h6vhtk-045808

    Publication Source

    Find a Tender Service

    Procurement Stage

    Tender

    Procurement Method

    Open

    Procurement Method Details

    Open Procedure

    Procurement Category

    Services

    Tender Suitability

    Framework / DPS

  • Contract Classification

    CPV Code(s)

    85100000

    CPV Division(s)

    85 - Health and social work services

  • Awarding Authority

    NHS ENGLAND

    Buyer Name

    Leigh Parker

    Buyer Email

    leigh.parker1@nhs.net

    Buyer Phone

    Buyer Address

    7-8 Wellington Place

    Leeds

    LS1 4AP

    United Kingdom

View contract on Find a Tender Service

TenderUpdate

Licence Variation: Spironolactone for acne in women

NHS ENGLAND

  • Contract Timeline

    Publication Date

    2nd July 2024 16:16:20 PM

  • Contract Summary

    NHS England requires a supplier to apply for a major (type II) MHRA Marketing Authorisation variation for spironolactone. The variation is to add a new indication to the current licence (marketing authorisation) for treating acne in women. The Successful Supplier would need to prepare a dossier for the MHRA including a Risk Management Plan, apply for the licence variation, and if granted update their licence, Summary of Product Characteristics and patient information leaflet with the new indication and related data.

    To register an interest in responding to this opportunity and obtain a copy of the tender documents please go to: http://health.atamis.co.uk. All communications and Request for Information submissions will be conducted via Atamis. The portal can be accessed at any time of the day and it is free to register.

  • Contract Details

    Open Contracting ID

    ocds-h6vhtk-045808

    Publication Source

    Find a Tender Service

    Procurement Stage

    TenderUpdate

    Procurement Method

    N/A

    Procurement Method Details

    N/A

    Procurement Category

    Services

    Tender Suitability

    Framework / DPS

  • Contract Classification

    CPV Code(s)

    85100000

    CPV Division(s)

    85 - Health and social work services

  • Awarding Authority

    NHS ENGLAND

    Buyer Name

    Leigh Parker

    Buyer Email

    england.commercialqueries@nhs.net

    Buyer Phone

    Buyer Address

    1st Floor, Quarry House, Quarry Hill

    Leeds

    LS2 7UE

    United Kingdom

View contract on Find a Tender Service

Tender

Licence Variation: Spironolactone for acne in women

NHS ENGLAND

  • Contract Timeline

    Publication Date

    19th June 2024 15:45:24 PM

    Tender Deadline

    31st July 2024 11:00:00 AM   Expired

  • Contract Summary

    NHS England requires a supplier to apply for a major (type II) MHRA Marketing Authorisation variation for spironolactone. The variation is to add a new indication to the current licence (marketing authorisation) for treating acne in women. The Successful Supplier would need to prepare a dossier for the MHRA including a Risk Management Plan, apply for the licence variation, and if granted update their licence, Summary of Product Characteristics and patient information leaflet with the new indication and related data.

    To register an interest in responding to this opportunity and obtain a copy of the tender documents please go to: http://health.atamis.co.uk. All communications and Request for Information submissions will be conducted via Atamis. The portal can be accessed at any time of the day and it is free to register.

  • Contract Details

    Open Contracting ID

    ocds-h6vhtk-045808

    Publication Source

    Find a Tender Service

    Procurement Stage

    Tender

    Procurement Method

    Open

    Procurement Method Details

    Open Procedure

    Procurement Category

    Services

    Tender Suitability

    Framework / DPS

  • Contract Classification

    CPV Code(s)

    85100000

    CPV Division(s)

    85 - Health and social work services

  • Awarding Authority

    NHS ENGLAND

    Buyer Name

    Leigh Parker

    Buyer Email

    england.commercialqueries@nhs.net

    Buyer Phone

    Buyer Address

    7-8 Wellington Place

    Leeds

    LS1 4AP

    United Kingdom

View contract on Find a Tender Service

Planning

Licence variation: Spironolactone for acne in women

NHS ENGLAND

  • Contract Timeline

    Publication Date

    8th May 2024 14:33:42 PM

  • Contract Summary

    NHS England has published this Prior Information Notice (PIN) in relation to securing a supplier to apply for a major (type II) MHRA Marketing Authorisation variation for spironolactone. The variation is to add a new indication to the current licence (marketing authorisation) for treating acne in women. The Successful Supplier would need to prepare a dossier for the MHRA including a Risk Management Plan, apply for the licence variation, and if granted update their licence, Summary of Product Characteristics and patient information leaflet with the new indication and related data.

    NHS England would like to gather soft intelligence from the market and is publishing a Request for Information.

    The Request for Information and further documentation will be available from 8 May 2024 and the deadline for responses will be 12 noon on 22 May 2024.

    To register an interest in responding to this market engagement exercise and obtain a copy of the Request for Information documentation please go to: http://health.atamis.co.uk. All communications and Request for Information submissions will be conducted via Atamis. The portal can be accessed at any time of the day and it is free to register.

  • Contract Details

    Open Contracting ID

    ocds-h6vhtk-045808

    Publication Source

    Find a Tender Service

    Procurement Stage

    Planning

    Procurement Method

    N/A

    Procurement Method Details

    N/A

    Procurement Category

    Services

    Tender Suitability

    Framework / DPS

  • Contract Classification

    CPV Code(s)

    85149000

    CPV Division(s)

    85 - Health and social work services

  • Awarding Authority

    NHS ENGLAND

    Buyer Name

    Leigh Parker

    Buyer Email

    england.commercialqueries@nhs.net

    Buyer Phone

    Buyer Address

    7-8 Wellington Place

    Leeds

    LS1 4AP

    United Kingdom

View contract on Find a Tender Service